NCT06555809View on ClinicalTrials.gov

Evaluation of Artesunate in Infants Being Treated for Severe Malaria

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

October 6, 2024

Primary Completion Date

August 31, 2029

Study Completion Date

February 28, 2030

Conditions
Malaria
Interventions
DRUG

Artesunate Injection

Additional blood sample will be collected when other standard of care blood specimens are collected during the 2-day period after the start of intravenous artesunate treatment.

Trial Locations (1)

75014

RECRUITING

Hôpital Cochin Port Royal, Paris

Sponsors

Lead Sponsor

Amivas Inc.
All Listed Sponsors
lead

Amivas Inc.

INDUSTRY

NCT06555809 - Evaluation of Artesunate in Infants Being Treated for Severe Malaria | Biotech Hunter | Biotech Hunter